LunaDNA, a connector of patients and pharmaceuticals, to shutter
LunaDNA, a company behind a health data platform that connects patient groups and companies like Biogen, is slated to close at the end of the month.
The San Diego company launched in 2017 to give patients a say in how their health data are used in drug research and development. Dawn Barry, LunaDNA’s president and co-founder, told Endpoints News that revenue was growing and profitability was starting to come into view, but it was difficult to obtain the next funding round amid a biotech downturn.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.